关于转移性胸腺瘤和胸腺癌的治疗选择的最新情况
Yoshihiro Masui1, Yusuke Okuma1
1Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
Expert review of anticancer therapy
|June 12, 2025
概括
胸膜恶性瘤的治疗因类型而异. 胸腺瘤对西斯普拉丁和环素有反应,而胸腺癌需要基于的化疗,而伦瓦提尼布对耐火病例显示出希望.
科学领域:
- 在瘤学瘤学.
- 胸部外科手术 胸部外科手术
- 药理学 药理学是指药理学的学科.
背景情况:
- 胸膜上皮瘤很少见,需要基于有限的试验数据制定治疗策略.
- 局部疾病的标准治疗包括手术,放射治疗和药物治疗.
- 药物治疗对于转移性和复发性胸膜恶性瘤至关重要.
研究的目的:
- 审查和差异化疗治疗策略的胸腺瘤和胸腺癌.
- 为突出当前和新兴的治疗选择为胸膜恶性瘤.
主要方法:
- 对胸膜上皮瘤治疗策略的文献综述.
- 对胸腺瘤和胸腺癌的化疗方案的分析.
- 确定当前研究中的关键药物和新疗法.
主要成果:
- 胸腺瘤通常对西斯普拉丁,人环素和类固醇有反应.
- 胸腺癌是用基于的双重化疗来治疗的,其中伦瓦提尼布是耐火病例的关键药物.
- 单剂细胞毒性化疗,向疗法和免疫检查点抑制剂是对胸膜癌的选择.
结论:
- 化疗方法在胸腺瘤和胸腺癌之间有很大的差异.
- 新型疗法包括抗体-药物合物和免疫检查点抑制剂正在研究中.
- 药物治疗在治疗晚期和复发的胸膜恶性瘤方面发挥着至关重要的作用.
相关概念视频
01:27Tumor Immunotherapy
491
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
491
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
02:30Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K